BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9387980)

  • 1. Variation in nebulizer output and weight output from Mefar dosimeter: implications for multicentre studies.
    Ward RJ; Reid DW; Walters EH
    Eur Respir J; 1997 Oct; 10(10):2436-7. PubMed ID: 9387980
    [No Abstract]   [Full Text] [Related]  

  • 2. Variation in nebulizer aerosol output and weight output from the Mefar dosimeter: implications for multicentre studies.
    Chinn S; Arossa WA; Jarvis DL; Luczynska CM; Burney PG
    Eur Respir J; 1997 Feb; 10(2):452-6. PubMed ID: 9042648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebulizer output for methacholine challenges with the KoKo Digidoser.
    Khan YR; McDonough P; Cockcroft DW; David BE; Hendeles L
    J Allergy Clin Immunol; 2005 Oct; 116(4):924-6. PubMed ID: 16210072
    [No Abstract]   [Full Text] [Related]  

  • 4. Calibration of aerosol output from the Mefar dosimeter: implications for epidemiological studies.
    Dennis JH; Avery AJ; Walters EH; Hendrick DJ
    Eur Respir J; 1992 Nov; 5(10):1279-82. PubMed ID: 1486976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 2 dosimeters by methacholine challenge.
    Hendeles L; Khan YR; Shuster JJ; Spencer T
    J Allergy Clin Immunol; 2007 Nov; 120(5):1218-9. PubMed ID: 17637473
    [No Abstract]   [Full Text] [Related]  

  • 6. A critical evaluation of the Mefar dosimeter.
    Ward RJ; Liakakos P; Leonard RF; Reid DW; Johns DP; Walters EH
    Eur Respir J; 1999 Aug; 14(2):430-4. PubMed ID: 10515425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardizing dose in dosimetric bronchial challenge tests.
    Malmberg LP; Kauppi P; Mäkelä MJ
    Clin Physiol Funct Imaging; 2018 Sep; 38(5):903-906. PubMed ID: 29345046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methacholine challenge methods.
    Cockcroft DW
    Chest; 2008 Oct; 134(4):678-680. PubMed ID: 18842907
    [No Abstract]   [Full Text] [Related]  

  • 9. A new method for measuring aerosol nebulizer output using radioactive tracers.
    Gatnash AA; Chandler ST; Connolly CK
    Eur Respir J; 1998 Aug; 12(2):467-71. PubMed ID: 9727803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of evaporative water losses during standardized nebulized inhalation provocation tests.
    Cockcroft DW; Hurst TS; Gore BP
    Chest; 1989 Sep; 96(3):505-8. PubMed ID: 2486186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methacholine Challenge Testing: A Novel Method for Measuring PD
    Davis BE; Simonson SK; Blais CM; Cockcroft DW
    Chest; 2017 Dec; 152(6):1251-1257. PubMed ID: 28923758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methacholine Challenge: Comparison of Airway Responsiveness Produced by a Vibrating Mesh Nebulizer Versus a Jet Nebulizer.
    Blais CM; Cockcroft DW; Veilleux J; Boulay MÈ; Boulet LP; Gauvreau GM; Scime TX; Watson RM; O'Byrne PM; Davis BE
    J Aerosol Med Pulm Drug Deliv; 2018 Apr; 31(2):88-93. PubMed ID: 28813613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provocative dose of methacholine causing a 20% drop in FEV1 should be used to interpret methacholine challenge tests with modern nebulizers.
    Dell SD; Bola SS; Foty RG; Marshall LC; Nelligan KA; Coates AL
    Ann Am Thorac Soc; 2015 Mar; 12(3):357-63. PubMed ID: 25575246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The physical and biological doses of methacholine are different for Mefar MB3 and Jaeger APS sidestream nebulizers.
    Praml G; Scharrer E; de la Motte D; Nowak D; Scheuch G; Sommerer K; Radon K
    Chest; 2005 Nov; 128(5):3585-9. PubMed ID: 16304317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of dosimeter calibration method on nebulizer output.
    Todd DC; Davis BE; Smycniuk AJ; Cockcroft DW
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):45-7. PubMed ID: 15702815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vitro study to investigate the use of a breath-actuated, small-volume, pneumatic nebulizer for the delivery of methacholine chloride bronchoprovocation agent.
    Mitchell JP; Nagel MW; Bates SL; Doyle CC
    Respir Care; 2003 Jan; 48(1):46-51. PubMed ID: 12556261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999.
    Crapo RO; Casaburi R; Coates AL; Enright PL; Hankinson JL; Irvin CG; MacIntyre NR; McKay RT; Wanger JS; Anderson SD; Cockcroft DW; Fish JE; Sterk PJ
    Am J Respir Crit Care Med; 2000 Jan; 161(1):309-29. PubMed ID: 10619836
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of driving pressure and nebulizer model on aerosol output during intermittent delivery with a dosimeter.
    Alkins SA; Hurwitz KM; Sierra A
    J Aerosol Med; 2002; 15(1):1-6. PubMed ID: 12006140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose vs concentration in methacholine challenge.
    Donado CD
    Ann Allergy Asthma Immunol; 2007 Jun; 98(6):598. PubMed ID: 17601278
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of two methacholine challenge methods using Spira-2 or Mefar dosimeter.
    Jõgi R; Janson C; Hedenström H
    Clin Physiol; 1999 Jul; 19(4):300-4. PubMed ID: 10451790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.